Immunic Inc. buy Brookline Capital Management
Start price
05.04.24
/
50%
€1.27
Target price
05.04.25
€9.25
Performance (%)
-28.99%
End price
06.04.25
€0.90
Summary
This prediction ended on 06.04.25 with a price of €0.90. The price of Immunic Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.99%. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunic Inc. | -14.800% | -14.800% | -1.045% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Brookline_Capital_Ma for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat
In the thread Trading Immunic Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten